Safe-Haven Assets Archives - Page 9 of 695

Replimune’s Recent FDA Progress Influences Stock Rating Change

Replimune’s stock received an upgrade post-FDA BLA acceptance, illustrating its potential impact on the biotech market.

The Moroccan stock market has risen recently, with the Index increasing by 2.55%. This article explores the factors behind this positive trend.

Turkey is committed to curbing inflation, facing challenges with currency volatility and consumer prices.

Weyerhaeuser’s stock hit a 52-week low, prompting analysis of factors and future market implications.

The Euro faces downward pressure, while the GBP remains stable despite economic challenges.

Diplomatic strategies are crucial in resolving tensions in Gaza as global powers engage to mediate negotiations for peace.

DeepGreenX has postponed its direct listing due to operational challenges, raising concerns about future prospects in the green energy market.

MARI’s recent acquisition of TodayTix signifies its commitment to enhancing customer engagement in the entertainment sector.

Argentina’s Central Bank has signed a significant $20 billion currency swap deal with the US to strengthen its financial stability.

Colombia’s recall of its ambassador from the US highlights growing trade tensions and economic concerns that could affect bilateral relations.